2
Announcements
Trials
Browse
Landscape
Phase
Phase NA
1
Status
Active not recruiting
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Conditions
Motor Activity
15
Breast Neoplasms
11
Neoplasms
8
Fatigue
8
Cognitive Dysfunction
3
Lung Neoplasms
2
Colorectal Neoplasms
2
Colonic Neoplasms
2
Stomach Neoplasms
1
Rectal Neoplasms
1
Prostatic Neoplasms
1
Postoperative Bowel Functions
1
Polycystic Ovary Syndrome
1
Parasomnias
1
Obesity
1
Multiple Endocrine Neoplasia Type 1
1
Metabolic Syndrome
1
Lymphoma, Follicular
1
Liver Neoplasms
1
Esophageal Neoplasms
1
Carcinoma, Non-Small-Cell Lung
1
Biliary Tract Neoplasms
1
Asthenia
1
Arthritis
1
Arthralgia
1
Adenomatous Polyps
1
Interventions
Metformin
7
Testosterone
2
Pioglitazone
2
Magnetic Resonance Spectroscopy
2
Inositol
2
Exercise
2
Ethinyl Estradiol
2
Blood Pressure
2
semaglutide
1
maltodextrin
1
drospirenone and ethinyl estradiol combination
1
drospirenone
1
bupropion hydrochloride, naltrexone hydrochoride drug combination
1
Walking
1
Vascular Stiffness
1
Ultrasonography
1
Triptorelin Pamoate
1
Topiramate
1
Tirzepatide
1
Sugars
1
Spironolactone
1
Qsymia
1
Pyruvic Acid
1
Pulse Wave Analysis
1
Preoperative Exercise
1
Phlebotomy
1
Phentermine
1
Pancreaticoduodenectomy
1
Orchiectomy
1
Observation
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Metabolic Syndrome
×
Walking
×
Clear all
NCT07157371
2025-09-05
SSAET
Riphah International University
Phase NA
Active not recruiting
60 enrolled